SAM #W81K0026QA231

Sole Source Lease and Supply of Cepheid GeneXpert Analyzers and Reagents for Army Medical Center

This opportunity concerns the Carl R. Darnall Army Medical Center's intent to award a sole source contract for molecular diagnostic equipment and supplies. - The requirement is for the lease of nine Cepheid GeneXpert analyzers and the ongoing procurement of compatible proprietary reagents and consumables. - These analyzers must be fully compatible with four existing Government-owned Cepheid analyzers to ensure clinical standardization and operational continuity. - Cepheid is the sole OEM; only their GeneXpert platform and reagents are acceptable due to proprietary technology and integration needs. - The procurement is classified under NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and PSC 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits, and Sets). - The contract is expected to be awarded around July 31, 2026, with option periods possible, subject to market research. - No set-aside applies; this is a sole source justification under 41 USC 1901 and FAR 13.501(a)(1)(ii). - Alternative solutions would require costly replacement of equipment and retraining, causing significant operational disruption.

Description

Notice of Intent to Award Sole Source and Redacted J&A

View original listing